Western Europe
Core European markets with established regulatory pathways and hospital tenders.
Markets
European quality,
international access.
From a European base, VARENQOR PHARMA works with distribution partners across four continents to bring documented, dependable medicines to market.
01 — Regions
Where we
operate.
Market entry is deliberate: we expand where regulatory pathways, partners and demand align.
Each market is served through partners who hold the right wholesale licences and understand local tender and reimbursement dynamics.
Central & Eastern Europe
High-volume generic demand served through regional distribution partners.
Middle East & North Africa
Registration-led market entry with local partners and tender participation.
Central Asia & Caucasus
Growing demand for affordable, documented European-quality products.
Latin America
Selective partnerships focused on cardiovascular and metabolic portfolios.
Sub-Saharan Africa
Access-driven supply for essential medicines through institutional channels.
02 — Supply chain
A chain built
to hold.
Supply planning
Rolling forecasts with partners so production slots are reserved before demand peaks.
Controlled transport
Temperature-monitored lanes with documented handovers at every stage.
Customs & registration
Market-specific documentation prepared alongside local regulatory partners.
Continuity buffers
European stock buffers reduce the impact of upstream disruption.
Areas served
- European Union
- European Economic Area
- DACH
- Central and Eastern Europe
- Middle East and North Africa
- Central Asia
- Latin America
- Sub-Saharan Africa
- Southeast Asia
Market entry
Bring VARENQOR
to your market.
We are open to new distribution partners in markets where we are not yet represented.
Become a partner